Cargando…
Effects of Qingda granule on patients with grade 1 hypertension at low-medium risk: study protocol for a randomized, controlled, double-blind clinical trial
BACKGROUND: Numerous pre-clinical studies showed that Qingda granule (QDG) was effective in treating hypertension. This study aims to evaluate the efficacy and safety of QDG in reducing blood pressure among patients with grade 1 hypertension at low-medium risk. METHODS: The study is designed as a ra...
Autores principales: | Long, Lin-zi, Chu, Jian-feng, Qu, Hua, Yang, Qiao-ning, Lu, Yan, Fu, Chang-geng, Peng, Jun, Chen, Ke-ji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806902/ https://www.ncbi.nlm.nih.gov/pubmed/36588157 http://dx.doi.org/10.1186/s13063-022-07006-0 |
Ejemplares similares
-
Qingda Granule Attenuates Angiotensin II-Induced Renal Apoptosis and Activation of the p53 Pathway
por: Long, Linzi, et al.
Publicado: (2022) -
Qingda granule prevents obesity-induced hypertension and cardiac dysfunction by inhibiting adverse Akt signaling activation
por: Gao, Qian, et al.
Publicado: (2022) -
Qingda Granule Attenuates Angiotensin II-Induced Blood Pressure and Inhibits Ca(2+)/ERK Signaling Pathway
por: Wu, Meizhu, et al.
Publicado: (2021) -
Effects of Bushen-Jiangya granules on blood pressure and pharmacogenomic evaluation in low-to-medium-risk hypertensive patients: study protocol for a randomized double-blind controlled trial
por: Yang, Xiaochen, et al.
Publicado: (2022) -
Effects of sang-qi granules on blood pressure and endothelial dysfunction in stage I or II hypertension: study protocol for a randomized double-blind double-simulation controlled trial
por: Shi, Haoyue, et al.
Publicado: (2020)